Tokyo, Oct. 21 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059479) titled 'A study on how caffeine affects concentration in relation to genetic factors' on Oct. 20.
Study Type:
Interventional
Study Design:
Basic Design - Cross-over
Randomization - Randomized
Blinding - Double blind -all involved are blinded
Control - Placebo
Primary Sponsor:
Institute - Waseda University
Condition:
Condition - Not applicable
Classification by malignancy - Others
Genomic information - YES
Objective:
Narrative objectives1 - The aim of this study is to clarify whether the effects of caffeine intake timing on cognitive function differ according to CYP1A2 genotype.
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - Following caffeine ingestion (6 mg/kg, administered in capsule form), the Psychomotor Vigilance Task (PVT) was initiated 25 minutes post-administration and consisted of seven repetitions of a 10-minute PVT followed by a 5-minute rest period.
Interventions/Control_2 - Following placebo ingestion (encapsulated in an identical capsule in appearance), the Psychomotor Vigilance Task (PVT) was initiated 25 minutes post-administration and consisted of seven repetitions of a 10-minute PVT followed by a 5-minute rest period.
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Male
Key inclusion criteria - Healthy males aged 18 to 39 years
Key exclusion criteria - Individuals with a history of chronic diseases
Individuals currently taking medication
Individuals with unstable sleep patterns
Target Size - 60
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 07 Month 29 Day
Anticipated trial start date - 2025 Year 11 Month 01 Day
Last follow-up date - 2027 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068028
Disclaimer: Curated by HT Syndication.
